nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Terbutaline—BCHE—kidney cancer	0.00913	0.522	CrCbGaD
Pirbuterol—Clenbuterol—CYP1A1—kidney cancer	0.00538	0.308	CrCbGaD
Pirbuterol—Nadolol—ABCB1—kidney cancer	0.00296	0.17	CrCbGaD
Pirbuterol—Insomnia—Erlotinib—kidney cancer	0.00221	0.00225	CcSEcCtD
Pirbuterol—Decreased appetite—Vinblastine—kidney cancer	0.00221	0.00225	CcSEcCtD
Pirbuterol—Chest pain—Sunitinib—kidney cancer	0.00221	0.00225	CcSEcCtD
Pirbuterol—Decreased appetite—Everolimus—kidney cancer	0.0022	0.00224	CcSEcCtD
Pirbuterol—Diarrhoea—Pazopanib—kidney cancer	0.0022	0.00224	CcSEcCtD
Pirbuterol—Fatigue—Everolimus—kidney cancer	0.00219	0.00222	CcSEcCtD
Pirbuterol—Stomatitis—Paclitaxel—kidney cancer	0.00217	0.00221	CcSEcCtD
Pirbuterol—Vomiting—Temsirolimus—kidney cancer	0.00217	0.00221	CcSEcCtD
Pirbuterol—Shock—Sorafenib—kidney cancer	0.00217	0.0022	CcSEcCtD
Pirbuterol—Dry mouth—Sunitinib—kidney cancer	0.00216	0.0022	CcSEcCtD
Pirbuterol—Rash—Temsirolimus—kidney cancer	0.00215	0.00219	CcSEcCtD
Pirbuterol—Dermatitis—Temsirolimus—kidney cancer	0.00215	0.00219	CcSEcCtD
Pirbuterol—Headache—Temsirolimus—kidney cancer	0.00214	0.00217	CcSEcCtD
Pirbuterol—Decreased appetite—Erlotinib—kidney cancer	0.00213	0.00216	CcSEcCtD
Pirbuterol—Dizziness—Pazopanib—kidney cancer	0.00212	0.00216	CcSEcCtD
Pirbuterol—Back pain—Vincristine—kidney cancer	0.00212	0.00216	CcSEcCtD
Pirbuterol—Oedema—Sunitinib—kidney cancer	0.00212	0.00216	CcSEcCtD
Pirbuterol—Alopecia—Gemcitabine—kidney cancer	0.00211	0.00215	CcSEcCtD
Pirbuterol—Fatigue—Erlotinib—kidney cancer	0.00211	0.00215	CcSEcCtD
Pirbuterol—Anorexia—Sorafenib—kidney cancer	0.0021	0.00214	CcSEcCtD
Pirbuterol—Feeling abnormal—Vinblastine—kidney cancer	0.0021	0.00213	CcSEcCtD
Pirbuterol—Feeling abnormal—Everolimus—kidney cancer	0.00209	0.00213	CcSEcCtD
Pirbuterol—Shock—Sunitinib—kidney cancer	0.00208	0.00212	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Vinblastine—kidney cancer	0.00208	0.00212	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Everolimus—kidney cancer	0.00207	0.00211	CcSEcCtD
Pirbuterol—Vomiting—Pazopanib—kidney cancer	0.00204	0.00208	CcSEcCtD
Pirbuterol—Rash—Pazopanib—kidney cancer	0.00202	0.00206	CcSEcCtD
Pirbuterol—Nausea—Temsirolimus—kidney cancer	0.00202	0.00206	CcSEcCtD
Pirbuterol—Dermatitis—Pazopanib—kidney cancer	0.00202	0.00206	CcSEcCtD
Pirbuterol—Anorexia—Sunitinib—kidney cancer	0.00202	0.00205	CcSEcCtD
Pirbuterol—Agitation—Vincristine—kidney cancer	0.00202	0.00205	CcSEcCtD
Pirbuterol—Back pain—Gemcitabine—kidney cancer	0.00201	0.00205	CcSEcCtD
Pirbuterol—Abdominal pain—Vinblastine—kidney cancer	0.00201	0.00205	CcSEcCtD
Pirbuterol—Headache—Pazopanib—kidney cancer	0.00201	0.00205	CcSEcCtD
Pirbuterol—Oedema—Dactinomycin—kidney cancer	0.002	0.00204	CcSEcCtD
Pirbuterol—Abdominal pain—Everolimus—kidney cancer	0.002	0.00204	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Erlotinib—kidney cancer	0.002	0.00204	CcSEcCtD
Pirbuterol—Hypoaesthesia—Paclitaxel—kidney cancer	0.00199	0.00203	CcSEcCtD
Pirbuterol—Abdominal pain—Erlotinib—kidney cancer	0.00193	0.00197	CcSEcCtD
Pirbuterol—Insomnia—Sunitinib—kidney cancer	0.00192	0.00195	CcSEcCtD
Pirbuterol—Decreased appetite—Sorafenib—kidney cancer	0.00191	0.00195	CcSEcCtD
Pirbuterol—Anorexia—Dactinomycin—kidney cancer	0.00191	0.00194	CcSEcCtD
Pirbuterol—Nausea—Pazopanib—kidney cancer	0.00191	0.00194	CcSEcCtD
Pirbuterol—Fatigue—Sorafenib—kidney cancer	0.0019	0.00193	CcSEcCtD
Pirbuterol—Weight increased—Capecitabine—kidney cancer	0.00187	0.0019	CcSEcCtD
Pirbuterol—Flushing—Paclitaxel—kidney cancer	0.00186	0.00189	CcSEcCtD
Pirbuterol—Decreased appetite—Sunitinib—kidney cancer	0.00184	0.00187	CcSEcCtD
Pirbuterol—Asthenia—Vinblastine—kidney cancer	0.00183	0.00186	CcSEcCtD
Pirbuterol—Fatigue—Sunitinib—kidney cancer	0.00183	0.00186	CcSEcCtD
Pirbuterol—Asthenia—Everolimus—kidney cancer	0.00182	0.00185	CcSEcCtD
Pirbuterol—Cough—Gemcitabine—kidney cancer	0.00182	0.00185	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Sorafenib—kidney cancer	0.0018	0.00183	CcSEcCtD
Pirbuterol—Pruritus—Everolimus—kidney cancer	0.00179	0.00183	CcSEcCtD
Pirbuterol—Oedema—Vincristine—kidney cancer	0.00179	0.00182	CcSEcCtD
Pirbuterol—Stomatitis—Capecitabine—kidney cancer	0.00178	0.00182	CcSEcCtD
Pirbuterol—Chest pain—Gemcitabine—kidney cancer	0.00177	0.0018	CcSEcCtD
Pirbuterol—Alopecia—Paclitaxel—kidney cancer	0.00177	0.0018	CcSEcCtD
Pirbuterol—Asthenia—Erlotinib—kidney cancer	0.00176	0.00179	CcSEcCtD
Pirbuterol—Decreased appetite—Dactinomycin—kidney cancer	0.00174	0.00177	CcSEcCtD
Pirbuterol—Diarrhoea—Vinblastine—kidney cancer	0.00174	0.00177	CcSEcCtD
Pirbuterol—Abdominal pain—Sorafenib—kidney cancer	0.00174	0.00177	CcSEcCtD
Pirbuterol—Diarrhoea—Everolimus—kidney cancer	0.00173	0.00177	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Sunitinib—kidney cancer	0.00173	0.00176	CcSEcCtD
Pirbuterol—Pruritus—Erlotinib—kidney cancer	0.00173	0.00176	CcSEcCtD
Pirbuterol—Fatigue—Dactinomycin—kidney cancer	0.00173	0.00176	CcSEcCtD
Pirbuterol—Tension—Paclitaxel—kidney cancer	0.00171	0.00174	CcSEcCtD
Pirbuterol—Anorexia—Vincristine—kidney cancer	0.00171	0.00174	CcSEcCtD
Pirbuterol—Oedema—Gemcitabine—kidney cancer	0.0017	0.00173	CcSEcCtD
Pirbuterol—Nervousness—Paclitaxel—kidney cancer	0.00169	0.00172	CcSEcCtD
Pirbuterol—Back pain—Paclitaxel—kidney cancer	0.00169	0.00172	CcSEcCtD
Pirbuterol—Dizziness—Vinblastine—kidney cancer	0.00168	0.00171	CcSEcCtD
Pirbuterol—Dizziness—Everolimus—kidney cancer	0.00168	0.00171	CcSEcCtD
Pirbuterol—Muscle spasms—Paclitaxel—kidney cancer	0.00168	0.00171	CcSEcCtD
Pirbuterol—Abdominal pain—Sunitinib—kidney cancer	0.00167	0.0017	CcSEcCtD
Pirbuterol—Diarrhoea—Erlotinib—kidney cancer	0.00167	0.0017	CcSEcCtD
Pirbuterol—Hypotension—Vincristine—kidney cancer	0.00167	0.0017	CcSEcCtD
Pirbuterol—Feeling abnormal—Dactinomycin—kidney cancer	0.00165	0.00168	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00164	0.00167	CcSEcCtD
Pirbuterol—Hypoaesthesia—Capecitabine—kidney cancer	0.00163	0.00166	CcSEcCtD
Pirbuterol—Tremor—Paclitaxel—kidney cancer	0.00163	0.00166	CcSEcCtD
Pirbuterol—Insomnia—Vincristine—kidney cancer	0.00162	0.00165	CcSEcCtD
Pirbuterol—Anorexia—Gemcitabine—kidney cancer	0.00162	0.00165	CcSEcCtD
Pirbuterol—Vomiting—Vinblastine—kidney cancer	0.00162	0.00165	CcSEcCtD
Pirbuterol—Dizziness—Erlotinib—kidney cancer	0.00162	0.00165	CcSEcCtD
Pirbuterol—Vomiting—Everolimus—kidney cancer	0.00161	0.00164	CcSEcCtD
Pirbuterol—Agitation—Paclitaxel—kidney cancer	0.0016	0.00163	CcSEcCtD
Pirbuterol—Rash—Everolimus—kidney cancer	0.0016	0.00163	CcSEcCtD
Pirbuterol—Dermatitis—Everolimus—kidney cancer	0.0016	0.00163	CcSEcCtD
Pirbuterol—Headache—Vinblastine—kidney cancer	0.00159	0.00162	CcSEcCtD
Pirbuterol—Headache—Everolimus—kidney cancer	0.00159	0.00162	CcSEcCtD
Pirbuterol—Hypotension—Gemcitabine—kidney cancer	0.00159	0.00162	CcSEcCtD
Pirbuterol—Abdominal pain—Dactinomycin—kidney cancer	0.00158	0.00161	CcSEcCtD
Pirbuterol—Asthenia—Sorafenib—kidney cancer	0.00158	0.00161	CcSEcCtD
Pirbuterol—Syncope—Paclitaxel—kidney cancer	0.00156	0.00159	CcSEcCtD
Pirbuterol—Decreased appetite—Vincristine—kidney cancer	0.00156	0.00158	CcSEcCtD
Pirbuterol—Pruritus—Sorafenib—kidney cancer	0.00156	0.00158	CcSEcCtD
Pirbuterol—Vomiting—Erlotinib—kidney cancer	0.00156	0.00158	CcSEcCtD
Pirbuterol—Fatigue—Vincristine—kidney cancer	0.00154	0.00157	CcSEcCtD
Pirbuterol—Rash—Erlotinib—kidney cancer	0.00154	0.00157	CcSEcCtD
Pirbuterol—Dermatitis—Erlotinib—kidney cancer	0.00154	0.00157	CcSEcCtD
Pirbuterol—Palpitations—Paclitaxel—kidney cancer	0.00154	0.00157	CcSEcCtD
Pirbuterol—Insomnia—Gemcitabine—kidney cancer	0.00154	0.00156	CcSEcCtD
Pirbuterol—Headache—Erlotinib—kidney cancer	0.00153	0.00156	CcSEcCtD
Pirbuterol—Loss of consciousness—Paclitaxel—kidney cancer	0.00153	0.00156	CcSEcCtD
Pirbuterol—Flushing—Capecitabine—kidney cancer	0.00153	0.00155	CcSEcCtD
Pirbuterol—Cough—Paclitaxel—kidney cancer	0.00152	0.00155	CcSEcCtD
Pirbuterol—Asthenia—Sunitinib—kidney cancer	0.00152	0.00155	CcSEcCtD
Pirbuterol—Nausea—Vinblastine—kidney cancer	0.00151	0.00154	CcSEcCtD
Pirbuterol—Somnolence—Gemcitabine—kidney cancer	0.00151	0.00154	CcSEcCtD
Pirbuterol—Migraine—Doxorubicin—kidney cancer	0.00151	0.00153	CcSEcCtD
Pirbuterol—Nausea—Everolimus—kidney cancer	0.00151	0.00153	CcSEcCtD
Pirbuterol—Diarrhoea—Sorafenib—kidney cancer	0.00151	0.00153	CcSEcCtD
Pirbuterol—Pruritus—Sunitinib—kidney cancer	0.0015	0.00152	CcSEcCtD
Pirbuterol—Chest pain—Paclitaxel—kidney cancer	0.00148	0.00151	CcSEcCtD
Pirbuterol—Anxiety—Paclitaxel—kidney cancer	0.00148	0.00151	CcSEcCtD
Pirbuterol—Decreased appetite—Gemcitabine—kidney cancer	0.00148	0.0015	CcSEcCtD
Pirbuterol—Fatigue—Gemcitabine—kidney cancer	0.00146	0.00149	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Vincristine—kidney cancer	0.00146	0.00149	CcSEcCtD
Pirbuterol—Dizziness—Sorafenib—kidney cancer	0.00146	0.00148	CcSEcCtD
Pirbuterol—Nausea—Erlotinib—kidney cancer	0.00145	0.00148	CcSEcCtD
Pirbuterol—Alopecia—Capecitabine—kidney cancer	0.00145	0.00148	CcSEcCtD
Pirbuterol—Dry mouth—Paclitaxel—kidney cancer	0.00145	0.00148	CcSEcCtD
Pirbuterol—Diarrhoea—Sunitinib—kidney cancer	0.00145	0.00147	CcSEcCtD
Pirbuterol—Asthenia—Dactinomycin—kidney cancer	0.00144	0.00146	CcSEcCtD
Pirbuterol—Confusional state—Paclitaxel—kidney cancer	0.00143	0.00146	CcSEcCtD
Pirbuterol—Oedema—Paclitaxel—kidney cancer	0.00142	0.00145	CcSEcCtD
Pirbuterol—Abdominal pain—Vincristine—kidney cancer	0.00142	0.00144	CcSEcCtD
Pirbuterol—Dizziness—Sunitinib—kidney cancer	0.0014	0.00143	CcSEcCtD
Pirbuterol—Feeling abnormal—Gemcitabine—kidney cancer	0.0014	0.00143	CcSEcCtD
Pirbuterol—Shock—Paclitaxel—kidney cancer	0.0014	0.00142	CcSEcCtD
Pirbuterol—Vomiting—Sorafenib—kidney cancer	0.0014	0.00142	CcSEcCtD
Pirbuterol—Tachycardia—Paclitaxel—kidney cancer	0.00139	0.00141	CcSEcCtD
Pirbuterol—Rash—Sorafenib—kidney cancer	0.00139	0.00141	CcSEcCtD
Pirbuterol—Dermatitis—Sorafenib—kidney cancer	0.00139	0.00141	CcSEcCtD
Pirbuterol—Back pain—Capecitabine—kidney cancer	0.00138	0.00141	CcSEcCtD
Pirbuterol—Headache—Sorafenib—kidney cancer	0.00138	0.0014	CcSEcCtD
Pirbuterol—Muscle spasms—Capecitabine—kidney cancer	0.00138	0.0014	CcSEcCtD
Pirbuterol—Diarrhoea—Dactinomycin—kidney cancer	0.00137	0.0014	CcSEcCtD
Pirbuterol—Anorexia—Paclitaxel—kidney cancer	0.00136	0.00138	CcSEcCtD
Pirbuterol—Vomiting—Sunitinib—kidney cancer	0.00135	0.00137	CcSEcCtD
Pirbuterol—Tremor—Capecitabine—kidney cancer	0.00134	0.00136	CcSEcCtD
Pirbuterol—Rash—Sunitinib—kidney cancer	0.00134	0.00136	CcSEcCtD
Pirbuterol—Dermatitis—Sunitinib—kidney cancer	0.00133	0.00136	CcSEcCtD
Pirbuterol—Hypotension—Paclitaxel—kidney cancer	0.00133	0.00135	CcSEcCtD
Pirbuterol—Headache—Sunitinib—kidney cancer	0.00133	0.00135	CcSEcCtD
Pirbuterol—Nausea—Sorafenib—kidney cancer	0.00131	0.00133	CcSEcCtD
Pirbuterol—Insomnia—Paclitaxel—kidney cancer	0.00129	0.00131	CcSEcCtD
Pirbuterol—Asthenia—Vincristine—kidney cancer	0.00129	0.00131	CcSEcCtD
Pirbuterol—Syncope—Capecitabine—kidney cancer	0.00128	0.00131	CcSEcCtD
Pirbuterol—Vomiting—Dactinomycin—kidney cancer	0.00127	0.0013	CcSEcCtD
Pirbuterol—Somnolence—Paclitaxel—kidney cancer	0.00126	0.00129	CcSEcCtD
Pirbuterol—Palpitations—Capecitabine—kidney cancer	0.00126	0.00129	CcSEcCtD
Pirbuterol—Rash—Dactinomycin—kidney cancer	0.00126	0.00129	CcSEcCtD
Pirbuterol—Nausea—Sunitinib—kidney cancer	0.00126	0.00128	CcSEcCtD
Pirbuterol—Loss of consciousness—Capecitabine—kidney cancer	0.00126	0.00128	CcSEcCtD
Pirbuterol—Cough—Capecitabine—kidney cancer	0.00125	0.00127	CcSEcCtD
Pirbuterol—Decreased appetite—Paclitaxel—kidney cancer	0.00124	0.00126	CcSEcCtD
Pirbuterol—Fatigue—Paclitaxel—kidney cancer	0.00123	0.00125	CcSEcCtD
Pirbuterol—Diarrhoea—Vincristine—kidney cancer	0.00123	0.00125	CcSEcCtD
Pirbuterol—Asthenia—Gemcitabine—kidney cancer	0.00122	0.00124	CcSEcCtD
Pirbuterol—Chest pain—Capecitabine—kidney cancer	0.00122	0.00124	CcSEcCtD
Pirbuterol—Anxiety—Capecitabine—kidney cancer	0.00121	0.00124	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—kidney cancer	0.0012	0.00123	CcSEcCtD
Pirbuterol—Pruritus—Gemcitabine—kidney cancer	0.0012	0.00122	CcSEcCtD
Pirbuterol—Dry mouth—Capecitabine—kidney cancer	0.00119	0.00121	CcSEcCtD
Pirbuterol—Nausea—Dactinomycin—kidney cancer	0.00119	0.00121	CcSEcCtD
Pirbuterol—Dizziness—Vincristine—kidney cancer	0.00118	0.00121	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—kidney cancer	0.00118	0.0012	CcSEcCtD
Pirbuterol—Confusional state—Capecitabine—kidney cancer	0.00118	0.0012	CcSEcCtD
Pirbuterol—Feeling abnormal—Paclitaxel—kidney cancer	0.00117	0.00119	CcSEcCtD
Pirbuterol—Oedema—Capecitabine—kidney cancer	0.00117	0.00119	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00116	0.00118	CcSEcCtD
Pirbuterol—Diarrhoea—Gemcitabine—kidney cancer	0.00116	0.00118	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—kidney cancer	0.00115	0.00117	CcSEcCtD
Pirbuterol—Shock—Capecitabine—kidney cancer	0.00115	0.00117	CcSEcCtD
Pirbuterol—Tachycardia—Capecitabine—kidney cancer	0.00114	0.00116	CcSEcCtD
Pirbuterol—Vomiting—Vincristine—kidney cancer	0.00114	0.00116	CcSEcCtD
Pirbuterol—Rash—Vincristine—kidney cancer	0.00113	0.00115	CcSEcCtD
Pirbuterol—Dermatitis—Vincristine—kidney cancer	0.00113	0.00115	CcSEcCtD
Pirbuterol—Abdominal pain—Paclitaxel—kidney cancer	0.00112	0.00114	CcSEcCtD
Pirbuterol—Headache—Vincristine—kidney cancer	0.00112	0.00114	CcSEcCtD
Pirbuterol—Anorexia—Capecitabine—kidney cancer	0.00111	0.00113	CcSEcCtD
Pirbuterol—Hypotension—Capecitabine—kidney cancer	0.00109	0.00111	CcSEcCtD
Pirbuterol—Vomiting—Gemcitabine—kidney cancer	0.00108	0.0011	CcSEcCtD
Pirbuterol—Rash—Gemcitabine—kidney cancer	0.00107	0.00109	CcSEcCtD
Pirbuterol—Dermatitis—Gemcitabine—kidney cancer	0.00107	0.00109	CcSEcCtD
Pirbuterol—Headache—Gemcitabine—kidney cancer	0.00106	0.00108	CcSEcCtD
Pirbuterol—Nausea—Vincristine—kidney cancer	0.00106	0.00108	CcSEcCtD
Pirbuterol—Insomnia—Capecitabine—kidney cancer	0.00106	0.00107	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—kidney cancer	0.00105	0.00107	CcSEcCtD
Pirbuterol—Asthenia—Paclitaxel—kidney cancer	0.00102	0.00104	CcSEcCtD
Pirbuterol—Decreased appetite—Capecitabine—kidney cancer	0.00101	0.00103	CcSEcCtD
Pirbuterol—Nausea—Gemcitabine—kidney cancer	0.00101	0.00103	CcSEcCtD
Pirbuterol—Fatigue—Capecitabine—kidney cancer	0.00101	0.00102	CcSEcCtD
Pirbuterol—Pruritus—Paclitaxel—kidney cancer	0.00101	0.00102	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—kidney cancer	0.000983	0.001	CcSEcCtD
Pirbuterol—Diarrhoea—Paclitaxel—kidney cancer	0.000973	0.000991	CcSEcCtD
Pirbuterol—Feeling abnormal—Capecitabine—kidney cancer	0.000962	0.000979	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000955	0.000972	CcSEcCtD
Pirbuterol—Dizziness—Paclitaxel—kidney cancer	0.000941	0.000957	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—kidney cancer	0.000936	0.000953	CcSEcCtD
Pirbuterol—Abdominal pain—Capecitabine—kidney cancer	0.000923	0.000939	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—kidney cancer	0.000905	0.000921	CcSEcCtD
Pirbuterol—Vomiting—Paclitaxel—kidney cancer	0.000905	0.000921	CcSEcCtD
Pirbuterol—Rash—Paclitaxel—kidney cancer	0.000897	0.000913	CcSEcCtD
Pirbuterol—Dermatitis—Paclitaxel—kidney cancer	0.000896	0.000912	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—kidney cancer	0.000896	0.000911	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—kidney cancer	0.000892	0.000908	CcSEcCtD
Pirbuterol—Headache—Paclitaxel—kidney cancer	0.000891	0.000907	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—kidney cancer	0.000887	0.000902	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—kidney cancer	0.000847	0.000862	CcSEcCtD
Pirbuterol—Nausea—Paclitaxel—kidney cancer	0.000845	0.00086	CcSEcCtD
Pirbuterol—Asthenia—Capecitabine—kidney cancer	0.000838	0.000853	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—kidney cancer	0.000827	0.000842	CcSEcCtD
Pirbuterol—Pruritus—Capecitabine—kidney cancer	0.000826	0.000841	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—kidney cancer	0.000815	0.000829	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—kidney cancer	0.00081	0.000825	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—kidney cancer	0.000805	0.000819	CcSEcCtD
Pirbuterol—Diarrhoea—Capecitabine—kidney cancer	0.000799	0.000813	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—kidney cancer	0.000785	0.000799	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—kidney cancer	0.000782	0.000796	CcSEcCtD
Pirbuterol—Dizziness—Capecitabine—kidney cancer	0.000772	0.000786	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—kidney cancer	0.000768	0.000781	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—kidney cancer	0.000759	0.000772	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—kidney cancer	0.000753	0.000766	CcSEcCtD
Pirbuterol—Vomiting—Capecitabine—kidney cancer	0.000742	0.000755	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—kidney cancer	0.00074	0.000754	CcSEcCtD
Pirbuterol—Rash—Capecitabine—kidney cancer	0.000736	0.000749	CcSEcCtD
Pirbuterol—Dermatitis—Capecitabine—kidney cancer	0.000735	0.000748	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—kidney cancer	0.000734	0.000748	CcSEcCtD
Pirbuterol—Headache—Capecitabine—kidney cancer	0.000731	0.000744	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—kidney cancer	0.000717	0.00073	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—kidney cancer	0.000703	0.000716	CcSEcCtD
Pirbuterol—Nausea—Capecitabine—kidney cancer	0.000693	0.000706	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—kidney cancer	0.000681	0.000693	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—kidney cancer	0.000669	0.000681	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—kidney cancer	0.000654	0.000666	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—kidney cancer	0.000649	0.00066	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—kidney cancer	0.00062	0.000631	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000615	0.000626	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—kidney cancer	0.000595	0.000605	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—kidney cancer	0.00054	0.00055	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—kidney cancer	0.000532	0.000542	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—kidney cancer	0.000515	0.000524	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—kidney cancer	0.000498	0.000506	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—kidney cancer	0.000478	0.000487	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—kidney cancer	0.000474	0.000483	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—kidney cancer	0.000474	0.000482	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—kidney cancer	0.000471	0.00048	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—kidney cancer	0.000447	0.000455	CcSEcCtD
